These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15632178)

  • 1. Mitotic phosphorylation rescues Abl from F-actin-mediated inhibition.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2005 Mar; 280(11):10318-25. PubMed ID: 15632178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of c-Abl tyrosine kinase activity by filamentous actin.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2001 Jul; 276(29):27104-10. PubMed ID: 11309382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Abl tyrosine kinase binds and phosphorylates phospholipid scramblase 1.
    Sun J; Zhao J; Schwartz MA; Wang JY; Wiedmer T; Sims PJ
    J Biol Chem; 2001 Aug; 276(31):28984-90. PubMed ID: 11390389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crk family adaptor proteins trans-activate c-Abl kinase.
    Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
    Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
    Mayer BJ; Baltimore D
    Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
    Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization.
    Master Z; Tran J; Bishnoi A; Chen SH; Ebos JM; Van Slyke P; Kerbel RS; Dumont DJ
    J Biol Chem; 2003 Aug; 278(32):30170-9. PubMed ID: 12777393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential SH3 domain-binding site in the Crk SH2 domain.
    Anafi M; Rosen MK; Gish GD; Kay LE; Pawson T
    J Biol Chem; 1996 Aug; 271(35):21365-74. PubMed ID: 8702917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.
    Glover RT; Angiolieri M; Kelly S; Monaghan DT; Wang JY; Smithgall TE; Buller AL
    J Biol Chem; 2000 Apr; 275(17):12725-9. PubMed ID: 10777567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
    Mayer BJ; Hirai H; Sakai R
    Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
    Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
    Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
    Chen S; O'Reilly LP; Smithgall TE; Engen JR
    J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity.
    Van Etten RA; Jackson PK; Baltimore D; Sanders MC; Matsudaira PT; Janmey PA
    J Cell Biol; 1994 Feb; 124(3):325-40. PubMed ID: 8294516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a binding site in c-Ab1 tyrosine kinase for the C-terminal repeated domain of RNA polymerase II.
    Baskaran R; Chiang GG; Wang JY
    Mol Cell Biol; 1996 Jul; 16(7):3361-9. PubMed ID: 8668151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain.
    Duyster J; Baskaran R; Wang JY
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1555-9. PubMed ID: 7533294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions.
    Weng Z; Rickles RJ; Feng S; Richard S; Shaw AS; Schreiber SL; Brugge JS
    Mol Cell Biol; 1995 Oct; 15(10):5627-34. PubMed ID: 7565714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.